Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.00
Ask: 34.00
Change: 2.50 (8.20%)
Spread: 2.00 (6.25%)
Open: 31.00
High: 33.00
Low: 31.00
Prev. Close: 30.50
SYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

5 May 2011 09:00

RNS Number : 9737F
System C Healthcare plc
05 May 2011
 



Not for release, publication or distribution, in whole or in part, in or into any jurisdiction where to do so would constitute a violation of the relevant laws of that jurisdiction

 

5 May 2011

 

System C Healthcare plc

("System C" or the "Company")

 

Contract with Gateshead Health NHS Foundation Trust

 

System C announces that the Company has signed a contract with Gateshead Health NHS Foundation Trust ("Gateshead Health") for the deployment and operation of a core strategic patient administration and electronic patient record (PAS/EPR) system.

 

Under the terms of the contract, the Company will supply Gateshead Health with its Medway suite of patient administration and clinical software for a minimum seven year period. The software will underpin the delivery of a full range of local acute services for elective and emergency care across the Gateshead area, as well as providing specialist services for people from the wider region.

 

Gateshead Health employs 3,390 people and has an annual income of £182m. Medway will be used by around 2,500 of the trust's clinical and administrative staff.

 

This contract is one of six the Company was shortlisted for at the time of its half-year report, published in January. It is the culmination of a six month OJEU procurement process against a wide range of competitor suppliers.

Ian Denley, Chief Executive Officer of System C, said: "This contract win is another significant endorsement of the Medway product suite and a tribute to the teams that work so hard developing and deploying our systems."

 

For further information, contact:

 

System C Healthcare plc

Dr Ian Denley, Chief Executive

 

Tel: 01622 691616

Charles Stanley Securities

Nominated Adviser

Russell Cook / Mark Taylor

 

Tel: 020 7149 6000

Maitland

Financial PR

Emma Burdett / Richard Farnsworth

 

Tel: 020 7379 5151

The directors of System C accept responsibility for the information contained in this Announcement. To the best of the knowledge and belief of the directors of System C (who have taken all reasonable care to ensure that such is the case) the information contained in this announcement is in accordance with the facts.

Charles Stanley Securities, which is authorised and regulated in the United Kingdom by the FSA is acting exclusively for System C and no one else in connection with the Acquisition and will not be responsible to anyone other than System C for providing the protections afforded to clients of Charles Stanley Securities nor for giving advice in relation to the Acquisition or any matter or arrangement referred to in this announcement.

The distribution of this Announcement in jurisdictions other than the United Kingdom may be restricted by the laws of those jurisdictions and therefore persons into whose possession this Announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of any such jurisdiction. This Announcement does not constitute an offer or an invitation to purchase or subscribe for any securities or a solicitation of an offer to buy any securities pursuant to this Announcement or otherwise in any jurisdiction in which such offer or solicitation is unlawful. This Announcement has been prepared in connection with proposals in relation to a scheme of arrangement pursuant to and for the purpose of complying with the laws of England and Wales, the City Code on Takeovers and Mergers (the "City Code") and the Rules of the London Stock Exchange and information disclosed may not be the same as that which would have been prepared in accordance with the laws of any jurisdiction outside England. Nothing in this Announcement should be relied on for any other purpose.

 

Dealing Disclosure requirements

Under Rule 8.3(a) of the City Code, any person who is interested in one per cent. or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an "Opening Position Disclosure" following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified.

An "Opening Position Disclosure" must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An "Opening Position Disclosure" by a person to whom Rule 8.3(a) of the City Code applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an "Opening Position Disclosure" must instead make a "Dealing Disclosure".

Under Rule 8.3(b) of the City Code, any person who is, or becomes, interested in one per cent. or more of any class of relevant securities of the offeree company or of any paper offeror must make a "Dealing Disclosure" if the person deals in any relevant securities of System C or of any paper offeror. A "Dealing Disclosure" must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A "Dealing Disclosure" by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of System C or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

"Opening Position Disclosures" must also be made by the offeree company and by any offeror and "Dealing Disclosures" must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the City Code).

Details of the offeree and offeror companies in respect of whose relevant securities "Opening Position Disclosures" and "Dealing Disclosures" must be made can be found in the "Disclosure Table" on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an "Opening Position Disclosure" or a "Dealing Disclosure", you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

Terms in quotation marks are defined in the Takeover Code, which can also be found on the Panel's website.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUSVRRABAVRUR
Date   Source Headline
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20247:00 amRNSBoard Change, Update & Change of Registered Office
12th Dec 20234:16 pmRNSBoard Changes
27th Nov 20237:00 amRNSHalf-year Report
1st Nov 20237:00 amRNSTrading Update & Notice of Results
26th Sep 20237:00 amRNSBoard Changes and Change of Adviser
22nd Sep 20232:22 pmRNSResult of AGM
5th Sep 20237:00 amRNSExercise of options and PDMR dealings
17th Aug 20237:00 amRNSNotice of AGM and Availability of ARA
7th Aug 20237:00 amRNSDirector / PDMR dealing
26th Jun 20237:01 amRNSBoard Changes and related party transactions
26th Jun 20237:00 amRNSFinal results for the year ended 31 March 2023
26th May 202312:05 pmRNSExercise of options and director dealing
26th May 20237:00 amRNSBoard Changes
26th Apr 202311:04 amRNSHolding(s) in Company
19th Apr 202310:08 amRNSHolding(s) in Company
18th Apr 20236:00 pmRNSHolding(s) in Company
18th Apr 20237:00 amRNSExec LTIP Awards
18th Apr 20237:00 amRNSHolding(s) in Company
17th Apr 20235:41 pmRNSHolding(s) in Company
17th Apr 20235:37 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
1st Feb 20237:00 amRNSChange of Adviser
31st Jan 20235:49 pmRNSSchedule 2(g) Update
21st Nov 20227:00 amRNSHalf-year Report
3rd Nov 20227:00 amRNSInvestor Presentation
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
26th Oct 20227:00 amRNSTrading Update
10th Oct 20225:28 pmRNSHolding(s) in Company
8th Sep 20221:12 pmRNSResult of AGM
28th Jul 202211:09 amRNSNotice of AGM & Availability of Annual Report
22nd Jun 20227:00 amRNSExecutive LTIP Awards
20th Jun 20227:00 amRNSFinal Results
8th Jun 202212:22 pmRNSInvestor Presentation
27th Apr 20227:00 amRNSAcquisition of Independent Network Solutions Ltd
19th Apr 20227:00 amRNSTrading Update and Notice of Results
5th Apr 20227:00 amRNSAcquisition of Truststream Security Solutions Ltd
4th Apr 20227:00 amRNSChange of Adviser
1st Apr 20225:05 pmRNSSchedule 2(g) update
22nd Nov 20217:00 amRNSHalf-year Report
8th Nov 202111:59 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSInvestor Presentation
29th Oct 20219:05 amRNSSecond Price Monitoring Extn
29th Oct 20219:00 amRNSPrice Monitoring Extension
29th Oct 20217:00 amRNSTrading Update and Notice of Results
16th Sep 202111:21 amRNSResult of AGM
23rd Aug 20217:00 amRNSNotice of AGM and Annual Report 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.